Matsuo Y - Search Results

1

Real-World Results of Stereotactic Body Radiotherapy for 399 Medically Operable Patients with Stage I Histology-Proven Non-Small Cell Lung Cancer.

Onishi H, Shioyama Y, Matsumoto Y, Matsuo Y, Miyakawa A, Yamashita H, Matsushita H, Aoki M, Nihei K, Kimura T, Ishiyama H, Murakami N, Nakata K, Takeda A, Uno T, Nomiya T, Taguchi H, Seo Y, Komiyama T, Marino K, Aoki S, Matsuda M, Akita T, Saito M. Onishi H, et al. Among authors: matsuo y. Cancers (Basel). 2023 Sep 1;15(17):4382. doi: 10.3390/cancers15174382. Cancers (Basel). 2023. PMID: 37686657 Free PMC article.

2

Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group.

Nagata Y, Hiraoka M, Mizowaki T, Narita Y, Matsuo Y, Norihisa Y, Onishi H, Shirato H. Nagata Y, et al. Among authors: matsuo y. Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):343-7. doi: 10.1016/j.ijrobp.2009.02.087. Int J Radiat Oncol Biol Phys. 2009. PMID: 19735861

3

Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer.

Matsuo Y, Shibuya K, Nagata Y, Takayama K, Norihisa Y, Mizowaki T, Narabayashi M, Sakanaka K, Hiraoka M. Matsuo Y, et al. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1104-11. doi: 10.1016/j.ijrobp.2009.12.022. Epub 2010 May 14. Int J Radiat Oncol Biol Phys. 2011. PMID: 20472343

4

Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma - benchmark for a prospective multi-institutional study.

Eriguchi T, Takeda A, Oku Y, Ishikura S, Kimura T, Ozawa S, Nakashima T, Matsuo Y, Nakamura M, Matsumoto Y, Yamazaki S, Sanuki N, Ito Y. Eriguchi T, et al. Among authors: matsuo y. Radiat Oncol. 2013 May 4;8:113. doi: 10.1186/1748-717X-8-113. Radiat Oncol. 2013. PMID: 23641879 Free PMC article.

5

Safety and effectiveness of stereotactic body radiotherapy for a clinically diagnosed primary stage I lung cancer without pathological confirmation.

Sakanaka K, Matsuo Y, Nagata Y, Maki S, Shibuya K, Norihisa Y, Narabayashi M, Ueki N, Mizowaki T, Hiraoka M. Sakanaka K, et al. Among authors: matsuo y. Int J Clin Oncol. 2014 Oct;19(5):814-21. doi: 10.1007/s10147-013-0637-3. Epub 2013 Nov 12. Int J Clin Oncol. 2014. PMID: 24218282

6

The impact of abdominal compression on outcome in patients treated with stereotactic body radiotherapy for primary lung cancer.

Mampuya WA, Matsuo Y, Ueki N, Nakamura M, Mukumoto N, Nakamura A, Iizuka Y, Kishi T, Mizowaki T, Hiraoka M. Mampuya WA, et al. Among authors: matsuo y. J Radiat Res. 2014 Sep;55(5):934-9. doi: 10.1093/jrr/rru028. Epub 2014 May 6. J Radiat Res. 2014. PMID: 24801474 Free PMC article.

7

Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients.

Yamashita H, Onishi H, Matsumoto Y, Murakami N, Matsuo Y, Nomiya T, Nakagawa K; Japanese Radiological Society multi-institutional SBRT study group (JRS-SBRTSG). Yamashita H, et al. Among authors: matsuo y. Radiat Oncol. 2014 May 10;9:112. doi: 10.1186/1748-717X-9-112. Radiat Oncol. 2014. PMID: 24886477 Free PMC article.

8

Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma.

Yamashita H, Onishi H, Murakami N, Matsumoto Y, Matsuo Y, Nomiya T, Nakagawa K; Japanese Radiological Society multi-institutional SBRT study group (JRS-SBRTSG). Yamashita H, et al. Among authors: matsuo y. J Radiat Res. 2015 May;56(3):561-7. doi: 10.1093/jrr/rru130. Epub 2015 Feb 16. J Radiat Res. 2015. PMID: 25691453 Free PMC article.

9

Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer with PTV<100 cc using a continual reassessment method (JCOG0702).

Onimaru R, Shirato H, Shibata T, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Onishi H. Onimaru R, et al. Among authors: matsuo y. Radiother Oncol. 2015 Aug;116(2):276-80. doi: 10.1016/j.radonc.2015.07.008. Epub 2015 Jul 29. Radiother Oncol. 2015. PMID: 26233591 Free article. Clinical Trial.

10

Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer: Importance of Salvage Surgery.

Hamaji M, Chen F, Matsuo Y, Ueki N, Hiraoka M, Date H. Hamaji M, et al. Among authors: matsuo y. J Thorac Oncol. 2015 Nov;10(11):1616-24. doi: 10.1097/JTO.0000000000000662. J Thorac Oncol. 2015. PMID: 26317918 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,293 results

Search Page